What drug is replacing Prolia?: Exploring Biosimilars and Alternative Treatments
•
4 min read
In March 2024, the FDA approved the first interchangeable biosimilars for denosumab, the active ingredient in Prolia. This shift has prompted many to ask: **what drug is replacing Prolia?** The answer involves biosimilars offering similar efficacy and safety at potentially lower costs, alongside unique alternative therapies like Evenity.
